JAZZ PHARMACEUTICALS FRANCE
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.
- First Posted Date
- 2008-07-09
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 125
- Registration Number
- NCT00711880
- Locations
- 🇬🇧
Clinical Trials Unit, The Walton Centre, Fazakerley, Liverpool, United Kingdom
A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
- First Posted Date
- 2008-07-09
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 189
- Registration Number
- NCT00711646
- Locations
- 🇬🇧
Royal Berkshire Hospital, Reading, Oxfordshire, United Kingdom
A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 297
- Registration Number
- NCT00710424
- Locations
- 🇬🇧
Royal Hallamshire Hospital, Sheffield, Yorkshire, United Kingdom
A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 246
- Registration Number
- NCT00710554
- Locations
- 🇬🇧
Pain Clinic Office, Gartnavel General Hospital,, Glasgow, West Lothain, United Kingdom
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 36
- Registration Number
- NCT00702468
- Locations
- 🇬🇧
James Paget University Hospital NHS Foundation Trust, Gorleston on Sea, Norfolk, United Kingdom
A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 572
- Registration Number
- NCT00681538
- Locations
- 🇬🇧
Department of Neurology, Northampton General Hospital, Cliftonville, Northampton, United Kingdom
A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
- Conditions
- Interventions
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 135
- Registration Number
- NCT00678795
- Locations
- 🇬🇧
Division of Clinical Neurology, Queen's Medical Centre, Nottingham, Notts, United Kingdom
Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 43
- Registration Number
- NCT00675948
- Locations
- 🇬🇧
Shropshire and Mid-Wales Hospice, Shrewsbury, United Kingdom
A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy
- Conditions
- Interventions
- First Posted Date
- 2008-05-08
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 177
- Registration Number
- NCT00674609
- Locations
- 🇬🇧
Shropshire and Mid-Wales Hospice, Shrewsbury, United Kingdom
A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel
- First Posted Date
- 2008-05-02
- Last Posted Date
- 2012-04-25
- Lead Sponsor
- Jazz Pharmaceuticals
- Registration Number
- NCT00670696
- Locations
- 🇬🇧
Merthyr Tydfill Industrial Estate, Merthyr, Tydfill, United Kingdom